Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Diabetes Research and Clinical Practice
|
May 23, 1998
Evidence for dissociation of insulin- and weight-reducing effects of metformin in non-diabetic male patients with coronary heart disease
S M Carlsen, V Grill, I Følling
Human Reproduction (Oxford, England)
|
April 4, 2009
Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome
S M Carlsen, E Vanky, R Fleming
Human Reproduction (Oxford, England)
|
March 5, 2004
Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin
E Vanky, K A Salvesen, S M Carlsen
Scandinavian Journal of Clinical and Laboratory Investigation
|
July 25, 2008
Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study
K J Fougner, E Vanky, S M Carlsen
Scandinavian Journal of Clinical and Laboratory Investigation
|
May 6, 2003
Androgen levels in pregnant women decrease with increasing maternal age
S M Carlsen, G Jacobsen, K S Bjerve
BJOG : an International Journal of Obstetrics and Gynaecology
|
December 16, 2011
Increased prevalence of diabetes and polycystic ovary syndrome in women with a history of preterm birth: a case-control study
T B Eilertsen, E Vanky, S M Carlsen
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
March 3, 2007
Metformin treatment in pregnant women with polycystic ovary syndrome--is reduced complication rate mediated by changes in the uteroplacental circulation?
K A Salvesen, E Vanky, S M Carlsen
Cytokine
|
March 17, 1998
Metformin increases circulating tumour necrosis factor-alpha levels in non-obese non-diabetic patients with coronary heart disease
S M Carlsen, A Waage, V Grill, et al.
Human Reproduction (Oxford, England)
|
May 1, 2004
Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study
S B Kjøtrød, V von Düring, S M Carlsen
European Journal of Endocrinology
|
May 3, 2013
Gestational diabetes mellitus among Norwegian women with polycystic ovary syndrome: prevalence and risk factors according to the WHO and the modified IADPSG criteria
R Helseth, E Vanky, O Salvesen, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Diabetes Research and Clinical Practice
|
May 23, 1998
Evidence for dissociation of insulin- and weight-reducing effects of metformin in non-diabetic male patients with coronary heart disease
S M Carlsen, V Grill, I Følling
Human Reproduction (Oxford, England)
|
April 4, 2009
Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome
S M Carlsen, E Vanky, R Fleming
Human Reproduction (Oxford, England)
|
March 5, 2004
Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin
E Vanky, K A Salvesen, S M Carlsen
Scandinavian Journal of Clinical and Laboratory Investigation
|
July 25, 2008
Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study
K J Fougner, E Vanky, S M Carlsen
Scandinavian Journal of Clinical and Laboratory Investigation
|
May 6, 2003
Androgen levels in pregnant women decrease with increasing maternal age
S M Carlsen, G Jacobsen, K S Bjerve
BJOG : an International Journal of Obstetrics and Gynaecology
|
December 16, 2011
Increased prevalence of diabetes and polycystic ovary syndrome in women with a history of preterm birth: a case-control study
T B Eilertsen, E Vanky, S M Carlsen
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
March 3, 2007
Metformin treatment in pregnant women with polycystic ovary syndrome--is reduced complication rate mediated by changes in the uteroplacental circulation?
K A Salvesen, E Vanky, S M Carlsen
Cytokine
|
March 17, 1998
Metformin increases circulating tumour necrosis factor-alpha levels in non-obese non-diabetic patients with coronary heart disease
S M Carlsen, A Waage, V Grill, et al.
Human Reproduction (Oxford, England)
|
May 1, 2004
Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study
S B Kjøtrød, V von Düring, S M Carlsen
European Journal of Endocrinology
|
May 3, 2013
Gestational diabetes mellitus among Norwegian women with polycystic ovary syndrome: prevalence and risk factors according to the WHO and the modified IADPSG criteria
R Helseth, E Vanky, O Salvesen, et al.
Page
of 4